IL33 and immunoglobulin G4-related sclerosing disease: Moreover, a recent IgG4‐RD cohort study found that hyperactive ILC2s secrete increased IL9 via IL33/ST2 stimulation, potentially promoting fibrosis through Treg activation and profibrotic TGFβ induction [103].